UK agency backs cancer drug after Sanofi cuts price

LONDON (Reuters) - Britain's healthcare cost watchdog NICE said on Friday it had changed its mind and decided to recommend Sanofi's prostate cancer drug Jevtana after the French company agreed to a further discount.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro